Recall of ZIMMER POWER SYSTEM - ELECTRIC HANDPIECE

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by ZIMMER BIOMET CANADA INC..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    98804
  • Event Risk Class
    II
  • Event Initiated Date
    2014-10-21
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Zimmer has initiated a recall of modular electric/battery double trigger and modular electric/battery single trigger handpieces with manufactured serial numbers below 400000 because of a potential malfunction. it is possible that the handpiece could start by itself when the power source is connected. the unexpected output of the device (start by itself) could lead to an injury to the user during usage or preparation of the device.

Device

  • Model / Serial
    Model Catalog: 89-8507-400-00 (Lot serial: >10 NUMBERS CONTACT MFR); Model Catalog: 89-8507-400-10 (Lot serial: >10 NUMBERS CONTACT MFR)
  • Product Description
    ZIMMER UNIVERSAL POWER SYSTEM HANDPIECE
  • Manufacturer

Manufacturer

  • Manufacturer Address
    MISSISSAUGA
  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.
  • Source
    HC